Cochrane Abstracts
Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Alpha‐1 Antitrypsin Augmentation Therapy for Treating Patients With Alpha‐1 Antitrypsin Deficiency and Lung Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434551/all/Intravenous_alpha‐1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha‐1_antitrypsin_deficiency_and_lung_disease.
Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434551/all/Intravenous_alpha‐1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha‐1_antitrypsin_deficiency_and_lung_disease. Accessed December 9, 2024.
Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434551/all/Intravenous_alpha‐1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha‐1_antitrypsin_deficiency_and_lung_disease
Intravenous Alpha‐1 Antitrypsin Augmentation Therapy for Treating Patients With Alpha‐1 Antitrypsin Deficiency and Lung Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434551/all/Intravenous_alpha‐1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha‐1_antitrypsin_deficiency_and_lung_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous alpha‐1 antitrypsin augmentation therapy for treating patients with alpha‐1 antitrypsin deficiency and lung disease
ID - 434551
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434551/all/Intravenous_alpha‐1_antitrypsin_augmentation_therapy_for_treating_patients_with_alpha‐1_antitrypsin_deficiency_and_lung_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
